{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:34:36Z","timestamp":1787852076547,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.lfs.2021.119267","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T17:10:37Z","timestamp":1614013837000},"page":"119267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Apoptosis signal-regulating kinase 1 inhibition reverses deleterious indoxyl sulfate-mediated endothelial effects"],"prefix":"10.1016","volume":"272","author":[{"given":"Feby","family":"Savira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Kompa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Magaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat M.","family":"Jucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Willette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.119267_bb0005","unstructured":"London, G.M., et al., Vascular and cardiac remodeling in end-stage renal disease. Nefrologia, 1997. 17(1): p. 17\u201322."},{"key":"10.1016\/j.lfs.2021.119267_bb0010","doi-asserted-by":"crossref","first-page":"938651","DOI":"10.4061\/2011\/938651","article-title":"Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management","volume":"2011","author":"Pateinakis","year":"2011","journal-title":"Int J Nephrol"},{"issue":"16","key":"10.1016\/j.lfs.2021.119267_bb0015","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2021.119267_bb0020","unstructured":"Liu, M., et al., Cardiovascular disease and its relationship with chronic kidney disease. Eur. Rev. Med. Pharmacol. Sci., 2014. 18(19): p. 2918\u201326."},{"key":"10.1016\/j.lfs.2021.119267_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension","volume":"956","author":"Konukoglu","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2021.119267_bb0030","unstructured":"Hadi, H.A., C.S. Carr, and J. Al Suwaidi, Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc. Health Risk Manag., 2005. 1(3): p. 183\u201398."},{"issue":"5","key":"10.1016\/j.lfs.2021.119267_bb0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2021.119267_bb0040","doi-asserted-by":"crossref","unstructured":"Goumans, M.J., Z. Liu, and P. ten Dijke, TGF-beta signaling in vascular biology and dysfunction. Cell Res., 2009. 19(1): p. 116\u201327. https:\/\/doi.org\/10.1038\/cr.2008.326.","DOI":"10.1038\/cr.2008.326"},{"issue":"2","key":"10.1016\/j.lfs.2021.119267_bb0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yexcr.2004.08.002","article-title":"TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms","volume":"301","author":"Akahane","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2021.119267_bb0050","doi-asserted-by":"crossref","unstructured":"Deltombe, O., et al., Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis. Toxins (Basel), 2015. 7(10): p. 3933\u201346. https:\/\/doi.org\/10.3390\/toxins7103933.","DOI":"10.3390\/toxins7103933"},{"key":"10.1016\/j.lfs.2021.119267_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.toxlet.2019.03.002","article-title":"Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy","volume":"308","author":"Savira","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2021.119267_bb0060","doi-asserted-by":"crossref","first-page":"439587","DOI":"10.1155\/2012\/439587","article-title":"Oxidative stress-induced diseases via the ASK1 signaling pathway","volume":"2012","author":"Soga","year":"2012","journal-title":"Int J Cell Biol"},{"issue":"6","key":"10.1016\/j.lfs.2021.119267_bb0065","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1517\/14728222.2014.896903","article-title":"Apoptosis signal-regulating kinase 1 as a therapeutic target","volume":"18","author":"Kawarazaki","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2021.119267_bb0070","doi-asserted-by":"crossref","unstructured":"Rastogi, S., et al., TNF-alpha response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73. Cell Death Differ., 2012. 19(2): p. 274\u201383. https:\/\/doi.org\/10.1038\/cdd.2011.93.","DOI":"10.1038\/cdd.2011.93"},{"issue":"2","key":"10.1016\/j.lfs.2021.119267_bb0075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ajpath.2012.10.008","article-title":"Apoptosis signal-regulating kinase 1 deficiency attenuates vascular injury-induced neointimal hyperplasia by suppressing apoptosis in smooth muscle cells","volume":"182","author":"Tasaki","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.lfs.2021.119267_bb0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/ATVBAHA.108.180349","article-title":"Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis","volume":"29","author":"Dai","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.lfs.2021.119267_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187459","article-title":"Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: implications for cardiorenal syndrome","volume":"12","author":"Savira","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2021.119267_bb0090","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.ijcard.2012.12.065","article-title":"Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome","volume":"168","author":"Liu","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.lfs.2021.119267_bb0095","doi-asserted-by":"crossref","first-page":"904","DOI":"10.5551\/jat.23663","article-title":"Aryl hydrocarbon receptor mediates indoxyl sulfate-induced cellular senescence in human umbilical vein endothelial cells","volume":"21","author":"Koizumi","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.lfs.2021.119267_bb0100","doi-asserted-by":"crossref","unstructured":"Ito, S., et al., Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin. J. Biol. Chem., 2010. 285(50): p. 38869\u201375. https:\/\/doi.org\/10.1074\/jbc.M110.166686.","DOI":"10.1074\/jbc.M110.166686"},{"issue":"14","key":"10.1016\/j.lfs.2021.119267_bb0105","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.lfs.2021.119267_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041281","article-title":"Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate","volume":"7","author":"Lekawanvijit","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2021.119267_bb0115","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119267_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2015.09.019","article-title":"Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120","volume":"243","author":"Six","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.lfs.2021.119267_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020338","article-title":"Acute exposure to indoxyl sulfate impairs endothelium-dependent vasorelaxation in rat aorta","volume":"20","author":"Matsumoto","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2021.119267_bb0130","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1248\/bpb.b19-00177","article-title":"Direct impairment of the endothelial function by acute indoxyl sulfate through declined nitric oxide and not endothelium-derived hyperpolarizing factor or vasodilator prostaglandins in the rat superior mesenteric artery","volume":"42","author":"Matsumoto","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2021.119267_bb0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijcard.2020.04.015","article-title":"Inhibition of apoptosis signal-regulating kinase 1 ameliorates left ventricular dysfunction by reducing hypertrophy and fibrosis in a rat model of cardiorenal syndrome","volume":"310","author":"Savira","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2021.119267_bb0140","unstructured":"Liles, J., et al., ASK1 promotes maladaptive remodeling in a rodent model of pulmonary hypertension. Eur. Respir. J., 2014. 44(Suppl 58): p. P2298."},{"key":"10.1016\/j.lfs.2021.119267_bb0145","doi-asserted-by":"crossref","DOI":"10.1172\/JCI99768","article-title":"ASK1 contributes to fibrosis and dysfunction in models of kidney disease","author":"Liles","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.lfs.2021.119267_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1164\/rccm.201703-0502OC","article-title":"ASK1 inhibition halts disease progression in preclinical models of pulmonary arterial hypertension","volume":"197","author":"Budas","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lfs.2021.119267_bb0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jbior.2017.10.011","article-title":"ASK family in cardiovascular biology and medicine","volume":"66","author":"Liu","year":"2017","journal-title":"Adv Biol Regul"},{"issue":"3","key":"10.1016\/j.lfs.2021.119267_bb0160","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/HYPERTENSIONAHA.107.092049","article-title":"Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency","volume":"50","author":"Yamashita","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.lfs.2021.119267_bb0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HJH.0b013e32833fc8b0","article-title":"Apoptosis signal-regulating kinase 1 deficiency eliminates cardiovascular injuries induced by high-salt diet","volume":"29","author":"Kataoka","year":"2011","journal-title":"J. Hypertens."},{"issue":"2","key":"10.1016\/j.lfs.2021.119267_bb0170","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2021.119267_bb0175","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/jcb.23435","article-title":"Effects of indoxyl sulfate on adherens junctions of endothelial cells and the underlying signaling mechanism","volume":"113","author":"Peng","year":"2012","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.lfs.2021.119267_bb0180","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2011.05.084","article-title":"Nitric oxide counters the inhibitory effects of uremic toxin indoxyl sulfate on endothelial cells by governing ERK MAP kinase and myosin light chain activation","volume":"409","author":"Kharait","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.lfs.2021.119267_bb0185","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.kint.2015.11.020","article-title":"Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization","volume":"89","author":"Hung","year":"2016","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.lfs.2021.119267_bb0190","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1159\/000465389","article-title":"Autocrine VEGF and IL-8 promote migration via Src\/Vav2\/Rac1\/PAK1 signaling in human umbilical vein endothelial cells","volume":"41","author":"Ju","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2021.119267_bb0195","doi-asserted-by":"crossref","unstructured":"Yamamoto, K., H. Ichijo, and S.J. Korsmeyer, BCL-2 is phosphorylated and inactivated by an ASK1\/Jun N-terminal protein kinase pathway normally activated at G(2)\/M. Mol. Cell. Biol., 1999. 19(12): p. 8469\u201378. https:\/\/doi.org\/10.1128\/mcb.19.12.8469.","DOI":"10.1128\/MCB.19.12.8469"},{"key":"10.1016\/j.lfs.2021.119267_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12726","article-title":"Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation","volume":"1347","author":"Scholz","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2021.119267_bb0205","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1172\/JCI99659","article-title":"Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction","volume":"128","author":"Lee","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.lfs.2021.119267_bb0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1681\/ASN.2008020243","article-title":"Roles of angiopoietins in kidney development and disease","volume":"20","author":"Woolf","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.lfs.2021.119267_bb0215","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1182\/blood-2007-08-110338","article-title":"Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8","volume":"111","author":"Abdel-Malak","year":"2008","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.lfs.2021.119267_bb0220","doi-asserted-by":"crossref","first-page":"e91828","DOI":"10.1172\/jci.insight.91828","article-title":"ASK1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis","volume":"2","author":"Yin","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.lfs.2021.119267_bb0225","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bbrc.2006.02.100","article-title":"Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9","volume":"342","author":"Yao","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.lfs.2021.119267_bb0230","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.99.3.420","article-title":"Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque","volume":"99","author":"Moreau","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2021.119267_bb0235","unstructured":"Sinha, S.K., et al., Nuclear localization of catalytically active MMP-2 in endothelial cells and neurons. Am. J. Transl. Res., 2014. 6(2): p. 155\u2013162."},{"key":"10.1016\/j.lfs.2021.119267_bb0240","doi-asserted-by":"crossref","unstructured":"Zhao, W.Q., et al., Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J. Cell Sci., 1998. 111 ( Pt 9): p. 1147\u201353.","DOI":"10.1242\/jcs.111.9.1147"},{"key":"10.1016\/j.lfs.2021.119267_bb0245","doi-asserted-by":"crossref","unstructured":"Lebrin, F., et al., TGF-beta receptor function in the endothelium. Cardiovasc. Res., 2005. 65(3): p. 599\u2013608. https:\/\/doi.org\/10.1016\/j.cardiores.2004.10.036.","DOI":"10.1016\/j.cardiores.2004.10.036"},{"issue":"2","key":"10.1016\/j.lfs.2021.119267_bb0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5551\/jat.13.82","article-title":"Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study","volume":"13","author":"Piao","year":"2006","journal-title":"J. Atheroscler. Thromb."},{"issue":"2","key":"10.1016\/j.lfs.2021.119267_bb0255","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jacc.2018.09.089","article-title":"Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review","volume":"73","author":"Kovacic","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119267_bb0260","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/cvr\/cvm049","article-title":"Nitric oxide regulates vascular calcification by interfering with TGF- signalling","volume":"77","author":"Kanno","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.lfs.2021.119267_bb0265","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.bjp.0706172","article-title":"Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis","volume":"145","author":"de Gouville","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2021.119267_bb0270","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000350843","article-title":"Removal of protein-bound uraemic toxins by haemodialysis","volume":"35","author":"Niwa","year":"2013","journal-title":"Blood Purif."},{"issue":"3","key":"10.1016\/j.lfs.2021.119267_bb0275","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00109-020-01878-y","article-title":"ASK1 inhibition: a therapeutic strategy with multi-system benefits","volume":"98","author":"Ogier","year":"2020","journal-title":"J Mol Med (Berl)"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521002526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521002526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:45:27Z","timestamp":1758401127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521002526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":55,"alternative-id":["S0024320521002526"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119267","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apoptosis signal-regulating kinase 1 inhibition reverses deleterious indoxyl sulfate-mediated endothelial effects","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119267"}}